CCA
RMD icon

Childress Capital Advisors’s ResMed RMD Stock Holding History

Childress Capital Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$259K Buy
+1,330
New +$276K 0.04% 309
2021
Q1 		– Sell
-69
Closed -$15K – 780
2020
Q4 		$15K Buy
+69
New +$13.8K 0.01% 432

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Childress Capital Advisors's RMD Position: Q2 2026 in Review

Childress Capital Advisors opened a new position in ResMed (RMD) in Q2 2026: 1,330 shares worth $259K. The stake represents 0.04% of the portfolio and ranks #309 among its holdings. This is a return to the name: Childress Capital Advisors previously reported a position in RMD as recently as Q4 2020.

Childress Capital Advisors first reported a position in RMD in Q4 2020 and has held it in 2 quarters since. 888 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Childress Capital Advisors held 1,330 shares of ResMed worth $259K as of Q2 2026.
  • ResMed was a new Childress Capital Advisors position in Q2 2026.
  • ResMed made up 0.04% of Childress Capital Advisors's portfolio in Q2 2026, its #309 holding.
  • Childress Capital Advisors first reported a position in ResMed in Q4 2020 and has held it in 2 quarters since.
  • 888 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Childress Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.